Ohio Poised to Permanently Ban Synthetic Kratom, Exempting Natural Product

Ohio Poised to Permanently Ban Synthetic Kratom, Exempting Natural Product

COLUMBUS, OH – Ohio is on the cusp of enacting a permanent ban on synthetic kratom compounds, a move strongly supported by State Representative Sean Patrick Brennan (D–Parma) and the Joint Committee on Agency Rule Review (JCARR). The proposed rule from the Ohio Board of Pharmacy, which was scheduled for a JCARR vote on April 13, 2026, aims to classify specific synthetic mitragynine-related compounds as Schedule I controlled substances, marking a significant development in the state's approach to kratom regulation.

This decision follows an emergency ban initiated by Governor Mike DeWine in December 2025, which temporarily outlawed synthetic kratom products and is set to expire on June 10, 2026. Importantly, this new rule explicitly exempts natural kratom in its vegetative form, such as kratom leaf or ground natural leaf, from the ban. Rep. Brennan emphasized that this is a "thoughtful and targeted step to protect Ohioans, especially our young people, from dangerous synthetic substances that are far more potent and unpredictable than their natural counterparts."

Why This Matters to Kratom Merchants and Consumers

For consumers, this action signifies a clearer distinction between natural kratom and potentially harmful synthetic alternatives, promoting greater product safety. The intent is to address immediate public health risks associated with synthetic compounds while allowing for continued evaluation of the natural product.

For kratom merchants, the impact is immediate and direct. Any business currently selling products containing synthetic kratom compounds, including highly concentrated 7-OH extracts, vapes, or gummies marketed as synthetic, must cease these sales in Ohio once the rule is adopted. The explicit exemption of natural kratom provides a degree of clarity for businesses dealing solely in the unprocessed form of the plant.

Compliance Implications for High-Risk Merchants

With the permanent ban on synthetic kratom compounds, compliance becomes paramount for all merchants operating in Ohio. Specifically, compounds such as 7-hydroxymitragynine, mitragynine pseudoindoxyl, dihydro-7-hydroxy mitragynine, and 7-acetoxymitragynine will be illegal to sell, possess, or distribute within the state. The ability to unequivocally differentiate between natural kratom and these prohibited synthetic or highly concentrated derivatives is no longer merely good practice, but a legal necessity.

What High-Risk Merchants Need to Know: COAs, Lab Testing, and Regulatory Compliance

High-risk merchants in the kratom industry must prioritize robust lab testing and transparency to navigate this evolving regulatory landscape.

1. Certificates of Analysis (COAs): Reliable COAs are critical to verify product purity and, most importantly, the absence of any synthetic compounds. These documents serve as proof that products comply with the new regulations.
2. Accurate Labeling: Products should be clearly labeled, stating whether they are pure natural leaf/powder or an extract. Any potency claims must be directly verifiable by an accompanying COA. Mislabeling could lead to severe legal repercussions.
3. Rigorous Lab Testing: Merchants must implement a stringent testing protocol to ensure their products are free from the now-banned synthetic compounds. This includes testing for the specific mitragynine-related compounds classified as Schedule I substances.
4. Continuous Regulatory Monitoring: The regulatory environment for kratom is constantly evolving, not just in Ohio but nationally. Merchants must stay informed about legislative discussions and proposed rules to ensure ongoing compliance.

This development in Ohio underscores a growing national trend towards distinguishing between natural kratom and its synthetic counterparts. For high-risk merchants, proactive and rigorous compliance measures, centered on transparent lab testing and adherence to evolving regulations, are essential for continued operation and mitigating legal risks.